Prospective Data in Adults from the ESC EORP European Endocarditis Registry

Bram Roosens,Bernard Cosyns,Patrizio Lancellotti,Cécile Laroche,Christine Selton-Suty,Agnès Pasquet,Johan De Sutter,Philippe Unger,Bernard Paelinck,Paul Vermeersch,Andreea Motoc,Xavier Galloo,Bernard Iung,Gilbert Habib,on behalf of the EURO-ENDO Investigators Group on behalf of the EURO-ENDO Investigators Group

DOI: https://doi.org/10.3390/jcm13051371

IF: 3.9

2024-02-29

Journal of Clinical Medicine

Abstract:(1) Background: infective endocarditis (IE) is a significant health concern associated with important morbidity and mortality. Only limited, often monocentric, retrospective data on IE in Belgium are available. This prospective study sought to assess the clinical characteristics and outcomes of Belgian IE patients in the ESC EORP European endocarditis (EURO-ENDO) registry; (2) Methods: 132 IE patients were identified based on the ESC 2015 criteria and included in six tertiary hospitals in Belgium; (3) Results: The average Belgian IE patient was male and 62.8 ± 14.9 years old. The native valve was most affected (56.8%), but prosthetic/repaired valves (34.1%) and intracardiac device-related (5.3%) IE are increasing. The most frequently identified microorganisms were S. aureus (37.2%), enterococci (15.5%), and C. burnetii (15.5%). The most frequent complications were acute renal failure (36.2%) and embolic events (23.6%). Cardiac surgery was effectively performed when indicated in 71.7% of the cases. In-hospital mortality occurred in 15.7% of patients. Predictors of mortality in the multivariate analysis were S. aureus (HR = 2.99 [1.07–8.33], p = 0.036) and unperformed cardiac surgery when indicated (HR = 19.54 [1.91–200.17], p = 0.012). (4) Conclusion: This prospective EURO-ENDO ancillary analysis provides valuable contemporary insights into the profile, treatment, and clinical outcomes of IE patients in Belgium.

medicine, general & internal

What problem does this paper attempt to address?

### Problems the Paper Aims to Address

This paper aims to evaluate the clinical characteristics and treatment outcomes of Belgian patients with infective endocarditis (IE) using data from the European Society of Cardiology (ESC) European Endocarditis Registry (EURO-ENDO). Specifically, this paper addresses the following issues:

1. **Patient Population Characteristics**: The paper describes the average age, gender distribution, and other basic characteristics of Belgian IE patients. The results show that the average age of Belgian IE patients is 62.8 years, with males being the majority.

2. **Infection Sites and Types**: The paper provides a detailed analysis of the types of heart valves affected by IE, including native valve endocarditis (NVE), prosthetic valve endocarditis (PVE), and cardiac device-related endocarditis (CDRIE). The study found that native valves are most commonly affected, but the proportion of prosthetic valve endocarditis is also increasing.

3. **Microbiological Characteristics**: The paper explores the most common types of pathogenic microorganisms. The study shows that Staphylococcus aureus (S. aureus) is the most common pathogen, followed by Enterococci and Streptococcus viridans (S. viridans).

4. **Complications**: The paper analyzes the occurrence of complications such as acute renal failure and embolic events. The results show that acute renal failure is the most common complication, followed by embolic events.

5. **Surgical Intervention**: The paper evaluates the situation of surgical treatment and its impact on patient prognosis. The study found that when surgery is needed, the implementation rate is high (71.7%), but some patients could not undergo surgery due to high risk and other reasons.

6. **Mortality and Its Predictors**: The paper discusses in-hospital mortality and identifies independent predictors of mortality through multivariable analysis. The results show that S. aureus infection and the lack of surgery when needed are the two main predictors of mortality.

In summary, this paper provides important contemporary data on Belgian IE patients, contributing to a better understanding of the clinical characteristics, diagnosis, and treatment outcomes of this disease.